ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amodiaquine Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-36A17316
Home | Market Reports | Health| Pharmacy
Global Amodiaquine Tablets Market Research Report 2024
BUY CHAPTERS

Global Amodiaquine Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-36A17316
Report
October 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Wellona Pharma
Healthy Life Pharma
Devlife Corporation
Sunrise
Actiza Pharmaceutical
Micro Labs
Advacare Pharma
SiNi Pharma

Amodiaquine Tablets Market

The global Amodiaquine Tablets market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Amodiaquine Tablets leading manufacturers including Wellona Pharma, Healthy Life Pharma, DevLife Corporation, Sunrise, Actiza Pharmaceutical, Micro Labs, AdvaCare Pharma, SiNi Pharma, etc., dominate supply; the top five capture approximately % of global revenue, with Wellona Pharma leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Amodiaquine Tablets market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Available Strength and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Amodiaquine Tablets Market Report

Report Metric Details
Report Name Amodiaquine Tablets Market
Segment by Available Strength
  • 100 mg
  • 200 mg
  • 600 mg
  • Others
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Wellona Pharma, Healthy Life Pharma, DevLife Corporation, Sunrise, Actiza Pharmaceutical, Micro Labs, AdvaCare Pharma, SiNi Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Amodiaquine Tablets study scope, segments the market by Available Strength and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Available Strength, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Available Strength, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Available Strength, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Available Strength, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Available Strength, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Amodiaquine Tablets Market report?

Ans: The main players in the Amodiaquine Tablets Market are Wellona Pharma, Healthy Life Pharma, DevLife Corporation, Sunrise, Actiza Pharmaceutical, Micro Labs, AdvaCare Pharma, SiNi Pharma

What are the Application segmentation covered in the Amodiaquine Tablets Market report?

Ans: The Applications covered in the Amodiaquine Tablets Market report are Hospitals, Clinics, Pharmacy

Recommended Reports

Treatment Devices

Tablet Markets

API and Drugs

1 Study Coverage
1.1 Introduction to Amodiaquine Tablets: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Available Strength
1.2.1 Global Amodiaquine Tablets Market Size by Available Strength, 2020 VS 2024 VS 2031
1.2.2 100 mg
1.2.3 200 mg
1.2.4 600 mg
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Amodiaquine Tablets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Amodiaquine Tablets Revenue Estimates and Forecasts 2020-2031
2.2 Global Amodiaquine Tablets Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Amodiaquine Tablets Sales Estimates and Forecasts 2020-2031
2.4 Global Amodiaquine Tablets Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Amodiaquine Tablets Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Amodiaquine Tablets Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 100 mg Market Size by Manufacturers
3.5.2 200 mg Market Size by Manufacturers
3.5.3 600 mg Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Amodiaquine Tablets Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Amodiaquine Tablets Sales Performance by Available Strength
4.1.1 Global Historical and Forecasted Sales by Available Strength (2020-2031)
4.1.2 Global Sales Market Share by Available Strength (2020-2031)
4.2 Global Amodiaquine Tablets Revenue Trends by Available Strength
4.2.1 Global Historical and Forecasted Revenue by Available Strength (2020-2031)
4.2.2 Global Revenue Market Share by Available Strength (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Available Strength (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Amodiaquine Tablets Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Amodiaquine Tablets Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Amodiaquine Tablets Sales and Revenue by Available Strength (2020-2031)
6.4 North America Amodiaquine Tablets Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Amodiaquine Tablets Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Amodiaquine Tablets Sales and Revenue by Available Strength (2020-2031)
7.4 Europe Amodiaquine Tablets Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Amodiaquine Tablets Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Amodiaquine Tablets Sales and Revenue by Available Strength (2020-2031)
8.4 Asia-Pacific Amodiaquine Tablets Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Amodiaquine Tablets Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Amodiaquine Tablets Sales and Revenue by Available Strength (2020-2031)
9.4 Central and South America Amodiaquine Tablets Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Amodiaquine Tablets Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Amodiaquine Tablets Sales and Revenue by Available Strength (2020-2031)
10.4 Middle East and Africa Amodiaquine Tablets Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Amodiaquine Tablets Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Wellona Pharma
11.1.1 Wellona Pharma Corporation Information
11.1.2 Wellona Pharma Business Overview
11.1.3 Wellona Pharma Amodiaquine Tablets Product Models, Descriptions and Specifications
11.1.4 Wellona Pharma Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Wellona Pharma Amodiaquine Tablets Sales by Product in 2024
11.1.6 Wellona Pharma Amodiaquine Tablets Sales by Application in 2024
11.1.7 Wellona Pharma Amodiaquine Tablets Sales by Geographic Area in 2024
11.1.8 Wellona Pharma Amodiaquine Tablets SWOT Analysis
11.1.9 Wellona Pharma Recent Developments
11.2 Healthy Life Pharma
11.2.1 Healthy Life Pharma Corporation Information
11.2.2 Healthy Life Pharma Business Overview
11.2.3 Healthy Life Pharma Amodiaquine Tablets Product Models, Descriptions and Specifications
11.2.4 Healthy Life Pharma Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Healthy Life Pharma Amodiaquine Tablets Sales by Product in 2024
11.2.6 Healthy Life Pharma Amodiaquine Tablets Sales by Application in 2024
11.2.7 Healthy Life Pharma Amodiaquine Tablets Sales by Geographic Area in 2024
11.2.8 Healthy Life Pharma Amodiaquine Tablets SWOT Analysis
11.2.9 Healthy Life Pharma Recent Developments
11.3 DevLife Corporation
11.3.1 DevLife Corporation Corporation Information
11.3.2 DevLife Corporation Business Overview
11.3.3 DevLife Corporation Amodiaquine Tablets Product Models, Descriptions and Specifications
11.3.4 DevLife Corporation Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 DevLife Corporation Amodiaquine Tablets Sales by Product in 2024
11.3.6 DevLife Corporation Amodiaquine Tablets Sales by Application in 2024
11.3.7 DevLife Corporation Amodiaquine Tablets Sales by Geographic Area in 2024
11.3.8 DevLife Corporation Amodiaquine Tablets SWOT Analysis
11.3.9 DevLife Corporation Recent Developments
11.4 Sunrise
11.4.1 Sunrise Corporation Information
11.4.2 Sunrise Business Overview
11.4.3 Sunrise Amodiaquine Tablets Product Models, Descriptions and Specifications
11.4.4 Sunrise Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sunrise Amodiaquine Tablets Sales by Product in 2024
11.4.6 Sunrise Amodiaquine Tablets Sales by Application in 2024
11.4.7 Sunrise Amodiaquine Tablets Sales by Geographic Area in 2024
11.4.8 Sunrise Amodiaquine Tablets SWOT Analysis
11.4.9 Sunrise Recent Developments
11.5 Actiza Pharmaceutical
11.5.1 Actiza Pharmaceutical Corporation Information
11.5.2 Actiza Pharmaceutical Business Overview
11.5.3 Actiza Pharmaceutical Amodiaquine Tablets Product Models, Descriptions and Specifications
11.5.4 Actiza Pharmaceutical Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Actiza Pharmaceutical Amodiaquine Tablets Sales by Product in 2024
11.5.6 Actiza Pharmaceutical Amodiaquine Tablets Sales by Application in 2024
11.5.7 Actiza Pharmaceutical Amodiaquine Tablets Sales by Geographic Area in 2024
11.5.8 Actiza Pharmaceutical Amodiaquine Tablets SWOT Analysis
11.5.9 Actiza Pharmaceutical Recent Developments
11.6 Micro Labs
11.6.1 Micro Labs Corporation Information
11.6.2 Micro Labs Business Overview
11.6.3 Micro Labs Amodiaquine Tablets Product Models, Descriptions and Specifications
11.6.4 Micro Labs Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Micro Labs Recent Developments
11.7 AdvaCare Pharma
11.7.1 AdvaCare Pharma Corporation Information
11.7.2 AdvaCare Pharma Business Overview
11.7.3 AdvaCare Pharma Amodiaquine Tablets Product Models, Descriptions and Specifications
11.7.4 AdvaCare Pharma Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AdvaCare Pharma Recent Developments
11.8 SiNi Pharma
11.8.1 SiNi Pharma Corporation Information
11.8.2 SiNi Pharma Business Overview
11.8.3 SiNi Pharma Amodiaquine Tablets Product Models, Descriptions and Specifications
11.8.4 SiNi Pharma Amodiaquine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SiNi Pharma Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Amodiaquine Tablets Industry Chain
12.2 Amodiaquine Tablets Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Amodiaquine Tablets Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Amodiaquine Tablets Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Amodiaquine Tablets Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Amodiaquine Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Wellona Pharma
Healthy Life Pharma
Devlife Corporation
Sunrise
Actiza Pharmaceutical
Micro Labs
Advacare Pharma
SiNi Pharma
List of Tables
 Table 1. Global Amodiaquine Tablets Market Size Growth Rate by Available Strength, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Amodiaquine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Amodiaquine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Amodiaquine Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Amodiaquine Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Amodiaquine Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Amodiaquine Tablets Sales by Region (2020-2025) & (Units)
 Table 8. Global Amodiaquine Tablets Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Amodiaquine Tablets Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Amodiaquine Tablets Sales Share by Manufacturers (2020-2025)
 Table 12. Global Amodiaquine Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Amodiaquine Tablets Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Amodiaquine Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amodiaquine Tablets as of 2024)
 Table 16. Global Amodiaquine Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Amodiaquine Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Amodiaquine Tablets Manufacturing Base and Headquarters
 Table 19. Global Amodiaquine Tablets Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Amodiaquine Tablets Sales by Available Strength (2020-2025) & (Units)
 Table 23. Global Amodiaquine Tablets Sales by Available Strength (2026-2031) & (Units)
 Table 24. Global Amodiaquine Tablets Revenue by Available Strength (2020-2025) & (US$ Million)
 Table 25. Global Amodiaquine Tablets Revenue by Available Strength (2026-2031) & (US$ Million)
 Table 26. Global Amodiaquine Tablets ASP by Available Strength (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Amodiaquine Tablets Sales by Application (2020-2025) & (Units)
 Table 29. Global Amodiaquine Tablets Sales by Application (2026-2031) & (Units)
 Table 30. Amodiaquine Tablets High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Amodiaquine Tablets Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Amodiaquine Tablets Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Amodiaquine Tablets ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Amodiaquine Tablets Growth Accelerators and Market Barriers
 Table 37. North America Amodiaquine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Amodiaquine Tablets Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Amodiaquine Tablets Growth Accelerators and Market Barriers
 Table 40. Europe Amodiaquine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Amodiaquine Tablets Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Amodiaquine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Amodiaquine Tablets Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Amodiaquine Tablets Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Amodiaquine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Amodiaquine Tablets Investment Opportunities and Key Challenges
 Table 47. Central and South America Amodiaquine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Amodiaquine Tablets Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Amodiaquine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Wellona Pharma Corporation Information
 Table 51. Wellona Pharma Description and Major Businesses
 Table 52. Wellona Pharma Product Models, Descriptions and Specifications
 Table 53. Wellona Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Wellona Pharma Sales Value Proportion by Product in 2024
 Table 55. Wellona Pharma Sales Value Proportion by Application in 2024
 Table 56. Wellona Pharma Sales Value Proportion by Geographic Area in 2024
 Table 57. Wellona Pharma Amodiaquine Tablets SWOT Analysis
 Table 58. Wellona Pharma Recent Developments
 Table 59. Healthy Life Pharma Corporation Information
 Table 60. Healthy Life Pharma Description and Major Businesses
 Table 61. Healthy Life Pharma Product Models, Descriptions and Specifications
 Table 62. Healthy Life Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Healthy Life Pharma Sales Value Proportion by Product in 2024
 Table 64. Healthy Life Pharma Sales Value Proportion by Application in 2024
 Table 65. Healthy Life Pharma Sales Value Proportion by Geographic Area in 2024
 Table 66. Healthy Life Pharma Amodiaquine Tablets SWOT Analysis
 Table 67. Healthy Life Pharma Recent Developments
 Table 68. DevLife Corporation Corporation Information
 Table 69. DevLife Corporation Description and Major Businesses
 Table 70. DevLife Corporation Product Models, Descriptions and Specifications
 Table 71. DevLife Corporation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. DevLife Corporation Sales Value Proportion by Product in 2024
 Table 73. DevLife Corporation Sales Value Proportion by Application in 2024
 Table 74. DevLife Corporation Sales Value Proportion by Geographic Area in 2024
 Table 75. DevLife Corporation Amodiaquine Tablets SWOT Analysis
 Table 76. DevLife Corporation Recent Developments
 Table 77. Sunrise Corporation Information
 Table 78. Sunrise Description and Major Businesses
 Table 79. Sunrise Product Models, Descriptions and Specifications
 Table 80. Sunrise Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Sunrise Sales Value Proportion by Product in 2024
 Table 82. Sunrise Sales Value Proportion by Application in 2024
 Table 83. Sunrise Sales Value Proportion by Geographic Area in 2024
 Table 84. Sunrise Amodiaquine Tablets SWOT Analysis
 Table 85. Sunrise Recent Developments
 Table 86. Actiza Pharmaceutical Corporation Information
 Table 87. Actiza Pharmaceutical Description and Major Businesses
 Table 88. Actiza Pharmaceutical Product Models, Descriptions and Specifications
 Table 89. Actiza Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Actiza Pharmaceutical Sales Value Proportion by Product in 2024
 Table 91. Actiza Pharmaceutical Sales Value Proportion by Application in 2024
 Table 92. Actiza Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 93. Actiza Pharmaceutical Amodiaquine Tablets SWOT Analysis
 Table 94. Actiza Pharmaceutical Recent Developments
 Table 95. Micro Labs Corporation Information
 Table 96. Micro Labs Description and Major Businesses
 Table 97. Micro Labs Product Models, Descriptions and Specifications
 Table 98. Micro Labs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Micro Labs Recent Developments
 Table 100. AdvaCare Pharma Corporation Information
 Table 101. AdvaCare Pharma Description and Major Businesses
 Table 102. AdvaCare Pharma Product Models, Descriptions and Specifications
 Table 103. AdvaCare Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. AdvaCare Pharma Recent Developments
 Table 105. SiNi Pharma Corporation Information
 Table 106. SiNi Pharma Description and Major Businesses
 Table 107. SiNi Pharma Product Models, Descriptions and Specifications
 Table 108. SiNi Pharma Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. SiNi Pharma Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Amodiaquine Tablets Product Picture
 Figure 2. Global Amodiaquine Tablets Market Size Growth Rate by Available Strength, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 100 mg Product Picture
 Figure 4. 200 mg Product Picture
 Figure 5. 600 mg Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Amodiaquine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Pharmacy
 Figure 11. Amodiaquine Tablets Report Years Considered
 Figure 12. Global Amodiaquine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Amodiaquine Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Amodiaquine Tablets Revenue Market Share by Region (2020-2031)
 Figure 16. Global Amodiaquine Tablets Sales (2020-2031) & (Units)
 Figure 17. Global Amodiaquine Tablets Sales (CAGR) by Region (2020-2031) (Units)
 Figure 18. Global Amodiaquine Tablets Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Amodiaquine Tablets Sales Volume Market Share in 2024
 Figure 20. Global Amodiaquine Tablets Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. 100 mg Revenue Market Share by Manufacturer in 2024
 Figure 23. 200 mg Revenue Market Share by Manufacturer in 2024
 Figure 24. 600 mg Revenue Market Share by Manufacturer in 2024
 Figure 25. Others Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Amodiaquine Tablets Sales Market Share by Available Strength (2020-2031)
 Figure 27. Global Amodiaquine Tablets Revenue Market Share by Available Strength (2020-2031)
 Figure 28. Global Amodiaquine Tablets Sales Market Share by Application (2020-2031)
 Figure 29. Global Amodiaquine Tablets Revenue Market Share by Application (2020-2031)
 Figure 30. North America Amodiaquine Tablets Sales YoY (2020-2031) & (Units)
 Figure 31. North America Amodiaquine Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Amodiaquine Tablets Sales Revenue (US$ Million) in 2024
 Figure 33. North America Amodiaquine Tablets Sales Volume (Units) by Available Strength (2020- 2031)
 Figure 34. North America Amodiaquine Tablets Sales Revenue (US$ Million) by Available Strength (2020 - 2031)
 Figure 35. North America Amodiaquine Tablets Sales Volume (Units) by Application (2020-2031)
 Figure 36. North America Amodiaquine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Amodiaquine Tablets Sales YoY (2020-2031) & (Units)
 Figure 41. Europe Amodiaquine Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Amodiaquine Tablets Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Amodiaquine Tablets Sales Volume (Units) by Available Strength (2020-2031)
 Figure 44. Europe Amodiaquine Tablets Sales Revenue (US$ Million) by Available Strength (2020-2031)
 Figure 45. Europe Amodiaquine Tablets Sales Volume (Units) by Application (2020-2031)
 Figure 46. Europe Amodiaquine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 48. France Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Amodiaquine Tablets Sales YoY (2020-2031) & (Units)
 Figure 53. Asia-Pacific Amodiaquine Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Amodiaquine Tablets Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Amodiaquine Tablets Sales Volume (Units) by Available Strength (2020- 2031)
 Figure 56. Asia-Pacific Amodiaquine Tablets Sales Revenue (US$ Million) by Available Strength (2020- 2031)
 Figure 57. Asia-Pacific Amodiaquine Tablets Sales Volume (Units) by Application (2020-2031)
 Figure 58. Asia-Pacific Amodiaquine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 63. India Amodiaquine Tablets Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Amodiaquine Tablets Sales YoY (2020-2031) & (Units)
 Figure 65. Central and South America Amodiaquine Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Amodiaquine Tablets Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Amodiaquine Tablets Sales Volume (Units) by Available Strength (2021-2031)
 Figure 68. Central and South America Amodiaquine Tablets Sales Revenue (US$ Million) by Available Strength (2020-2031)
 Figure 69. Central and South America Amodiaquine Tablets Sales Volume (Units) by Application (2020-2031)
 Figure 70. Central and South America Amodiaquine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Amodiaquine Tablets Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Amodiaquine Tablets Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Amodiaquine Tablets Sales YoY (2020-2031) & (Units)
 Figure 74. Middle East and Africa Amodiaquine Tablets Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Amodiaquine Tablets Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Amodiaquine Tablets Sales Volume (Units) by Available Strength (2021-2031)
 Figure 77. South America Amodiaquine Tablets Sales Revenue (US$ Million) by Available Strength (2020-2031)
 Figure 78. Middle East and Africa Amodiaquine Tablets Sales Volume (Units) by Application (2020-2031)
 Figure 79. Middle East and Africa Amodiaquine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Amodiaquine Tablets Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Amodiaquine Tablets Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Amodiaquine Tablets Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Amodiaquine Tablets Revenue (2020-2025) & (US$ Million)
 Figure 84. Amodiaquine Tablets Industry Chain Mapping
 Figure 85. Regional Amodiaquine Tablets Manufacturing Base Distribution (%)
 Figure 86. Global Amodiaquine Tablets Production Market Share by Region (2020-2031)
 Figure 87. Amodiaquine Tablets Production Process
 Figure 88. Regional Amodiaquine Tablets Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Amodiaquine Hydrochloride Market Research Report 2024
Global Hydroxychloroquine Sulfate Tablets Market Research Report 2024
Global Mefloquine Market Research Report 2025
Global Primaquine Market Research Report 2025
Global Meloxicam Tablets Market Research Report 2024
Malaria Prescription Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dapsone Tablets Market Research Report 2024
Global Isoniazid Tablets Market Research Report 2024
Global Ritonavir Tablets Market Research Report 2024
Global Gliquidone Tablets Market Research Report 2024
Global Sitafloxacin Tablets Market Research Report 2024
Global Lamotrigine Tablets Market Research Report 2024
Global Methotrexate Tablets Market Research Report 2025
Metronidazole Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Naproxen Tablets Market Research Report 2024
Global Mizoribine Tablets Market Research Report 2024
Acarbose Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oxytetracycline Tablets Market Research Report 2024
Global Pazopanib Tablets Market Research Report 2024
Global Aceclofenac Tablets Market Research Report 2024

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions